What Calcidose Vitamine D3 Treats: Main Therapeutic Areas

Calcidose Vitamine D3 is commonly used to address symptoms related to systemic imbalance and physical discomfort caused by calcium and vitamin D deficiency, which may create noticeable physiological strain on the skeletal system.

The combination product containing calcium carbonate and cholecalciferol (Vitamin D3) may be part of symptomatic management in conditions where functional stability becomes affected. This includes clinical scenarios where there is a risk of osteoporosis (bone thinning) or when managing existing deficiency states like osteomalacia. This preparation is used to help prevent or manage bone loss, particularly in elderly individuals or those with insufficient dietary intake.

The supportive relief helps ease the overall symptom burden associated with weakened bones, and the components contribute to maintaining skeletal health and functional stability during symptomatic phases. This provides assistance when symptoms become temporarily overwhelming.

“The combination’s components support patients during difficult episodes by easing distress and helping them cope more steadily with symptom fluctuations.”

Quick Fact: Relief for Symptoms that Interfere with Daily Functioning

Regulatory References

1. NHS Guidance on Calcium and Vitamin D Preparations

Who can and cannot use Calcidose Vitamine D3?

The official eligibility profile for Calcidose Vitamine D3 (Calcium Carbonate and Cholecalciferol) defines populations for use and those for whom the medicine is strictly prohibited.

Eligibility Category	Regulatory Status and Description
Populations for whom use is allowed	Adults and the Elderly are the primary populations for whom use is indicated (Source 1.4, 2.3).
Populations for whom use is contraindicated	Patients with Hypercalcaemia, Hypercalciuria, Hypervitaminosis D, and Severe Renal Impairment must not use this medicine (Source 1.1, 2.7).
Age-related eligibility rules	Use is not recommended for children and adolescents under 18 years of age, often due to the high vitamin D content in the specific formulations (Source 2.5, 2.7).
Pregnancy and lactation eligibility status	High-dose products are not recommended; use is restricted to low-dose preparations during pregnancy and breastfeeding (Source 2.5, 3.5).

Eligibility-related restrictions also apply to patients with specific comorbidities. The medicine must be used with caution and under medical monitoring in patients with Sarcoidosis and non-severe Renal Impairment (Source 2.5). Contraindications also include Nephrolithiasis (kidney stones) and Nephrocalcinosis (Source 1.2, 2.7).

Interactions with other medicines and products

This section outlines interactions with other medicinal products and substances as officially documented in government regulatory labeling for the combination of Calcium Carbonate and Cholecalciferol (Vitamin D3).

---

Documented Interaction Patterns

Official regulatory documents classify certain combinations as contraindicated, specifically with other Vitamin D analogs, due to the risk of hypercalcemia and hypervitaminosis D.

Pharmacodynamic interactions require specific caution when co-administering with Cardiac Glycosides (like Digoxin) and Thiazide Diuretics. Hypercalcemia associated with the combination may potentiate the effects of cardiac glycosides, increasing the risk of arrhythmias, while thiazides may increase the risk of hypercalcemia by reducing calcium excretion.

Timing and Absorption Restrictions

Interactions involving chelation or binding by the calcium component necessitate mandatory timing separation to prevent reduced drug absorption. Regulatory labeling specifies separation rules for:

• Tetracycline and Quinolone Antibiotics: Must be taken at separate times (e.g., two to six hours apart).
• Bisphosphonates and Levothyroxine: Require specified separation intervals (e.g., at least one hour before or four hours apart, respectively).

Additionally, enzyme-inducing anticonvulsants (such as Phenytoin) may reduce the efficacy of the Vitamin D3 component through documented increased metabolic catabolism. Foods high in oxalic or phytic acid (e.g., bran, spinach) may also interfere with calcium absorption, necessitating a separation of administration.

Vitamin D Metabolism and Receptor Activation

The action of Calcidose Vitamine D3 is centered on its two active components, calcium and Vitamin D3, which modulate mineral balance within specific physiological systems. The Vitamin D3 (cholecalciferol) component undergoes metabolic conversion into the active hormone, calcitriol, primarily in the liver and kidneys. Calcitriol acts as a ligand that binds to the Vitamin D Receptor (VDR), initiating genomic signaling that controls the expression of mineral-transport proteins.

️ Regulation of Intestinal Mineral Transport

This mechanism involves the active Vitamin D hormone increasing the capacity for absorbing dietary calcium and phosphate across the wall of the small intestine. This increased uptake, coupled with the supplemental calcium, modulates the total systemic mineral load.

Impact on Skeletal Mineralization and Neuromuscular Excitability

The resulting physiological effect is the stabilization of serum calcium levels. This stabilization contributes to the deposition of calcium and phosphate ions into the bone matrix. Additionally, circulating calcium modulates the electrochemical gradient required for nerve depolarization and muscle cell excitability.

How to Use Calcidose Vitamine D3: Official Administration Guidelines

Calcidose Vitamine D3 (Calcium Carbonate 500 mg / Cholecalciferol 400 IU) is a powder intended for oral solution only, and its use must strictly follow the provided instructions for this medication.

---

Standard Dosing and Preparation

Administration Detail	Standard Instruction
Route	Oral route only.
Standard Adult Dose	Two sachets per day. This delivers a total daily intake of 1000 mg elemental calcium and 800 IU of Vitamin D3.
Frequency	The total daily dose is typically administered as two separate, divided doses (e.g., one sachet in the morning and one sachet in the evening).
Preparation	The powder content of the sachet must be fully diluted in a glass of water immediately before consumption.
Timing	Taking the medicine with a meal is generally recommended to support the absorption of calcium.

---

Procedural Instructions and Use Restrictions

The official guidance defines the correct administration and procedural limits:

• Dose Administration: To take the medicine, the powder must be dissolved entirely in water, and the solution must be drunk immediately after mixing.
• Missed Dose: If an administration is missed, the patient should not double the next dose to compensate, but should continue with the regular schedule.
• Use Duration: Calcidose Vitamine D3 is often used for long-term maintenance and supportive therapy; the precise duration of use should be consistent with medical prescription.
• Pregnancy: During pregnancy, the daily intake should not exceed one sachet of the 500 mg/400 IU formulation.

This medicine is reserved for adult use. No dose adjustment is required for hepatic impairment. However, use is generally restricted in patients with severe renal impairment due to the cholecalciferol content.

Overview of Clinical Research

Calcidose Vitamine D3 combines calcium carbonate and cholecalciferol (Vitamin D3), a long-established formulation used for addressing deficiencies of these nutrients. Clinical use is primarily supported by decades of data demonstrating the essential roles of calcium and Vitamin D in skeletal health and mineral homeostasis.

Evidence for this combination is often categorized within broader research on Vitamin D supplementation, particularly in populations at high risk for deficiency, such as the elderly. Studies have consistently confirmed that Vitamin D supplementation is effective in raising and maintaining serum levels of 25-hydroxyvitamin D, the standard marker for Vitamin D status in the body.

---

Key Research Findings

Research Focus	Study Observation
Deficiency Correction	Supplementation with Vitamin D3 is associated with increased serum 25(OH)D concentrations, helping to address established deficiency.
Bone Health	The combination of Vitamin D3 and calcium has been assessed as an adjunct to specific osteoporosis treatments to help maintain bone mineral density and reduce the risk of fractures in high-risk patients.
Safety Profile	At doses commonly used for supplementation, the combination has generally been reported to be well-tolerated. Potential adverse effects, such as hypercalcemia, are typically linked to excessive intake and require monitoring, especially in susceptible individuals.

---

Broader Context

While the primary established use relates to mineral and bone disorders, emerging research explores the role of Vitamin D in extraskeletal functions, including immune response and cardiovascular health. However, data from large-scale randomized controlled trials regarding broader health benefits remains mixed or inconclusive, necessitating further rigorous study to establish clear clinical guidelines beyond its foundational use for calcium and Vitamin D deficiency.

Key Studies & References

1. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication - Final Recommendation Statement (USPSTF) (Used for broader context on the balance of benefits and harms)
2. Calcium and/or Vitamin D Supplementation for the Prevention of Fragility Fractures: Who Needs It? (Review of fracture trials and meta-analyses)

Common questions about Calcidose Vitamine D3 (FAQ)

---

Q: Are there any long-term safety concerns with Calcidose Vitamine D3?

Official documents describe that for long-term treatment, monitoring of certain clinical parameters is advised. This can include monitoring levels of calcium in the blood and urine and kidney function. Treatment may be temporarily reduced or stopped if calcium levels rise too high (hypercalciuria).

---

Q: Can pregnant or breastfeeding women use Calcidose Vitamine D3?

During pregnancy, the medicine is permitted only if there is a documented deficiency, and the daily intake limits for calcium and Vitamin D should be consistent with the official limits. For breastfeeding, regulatory documents note that Vitamin D and its metabolites do pass into breast milk, which is a factor to consider if the infant is also receiving supplements.

---

Q: Can people with lactose intolerance take Calcidose Vitamine D3?

The official list of ingredients for this specific formulation of Calcidose Vitamine D3 powder generally does not include lactose among its excipients (non-active ingredients). Patients are generally advised to review the official product leaflet for the excipient list specific to their formulation.

---

Q: Are there any warnings about operating machinery or driving while using Calcidose Vitamine D3?

Regulatory documents state that based on how the drug works and the reported potential side effects, Calcidose Vitamine D3 is unlikely to affect the ability to drive or operate machinery.

---

Q: Can older adults use Calcidose Vitamine D3 safely?

The medicine is reserved for adult use, and official documents confirm that no dose adjustment is typically required for the elderly. However, monitoring of kidney function and calcium levels is often advised for older adults, especially during continuous, long-term use.

---

Q: Why is it important to check existing calcium and Vitamin D levels before using this medicine?

Monitoring of levels is necessary because regulatory information states the medicine is contraindicated if a patient already has excessively high levels of calcium (hypercalcaemia) or Vitamin D (hypervitaminosis D). Monitoring helps ensure mineral levels stay within a safe range during treatment.

---

Q: Is Calcidose Vitamine D3 a prescription or an over-the-counter medicine?

The regulatory classification for this specific combination product varies by country, but in its registered markets, it is generally classified as a prescription drug or a product requiring pharmacist supervision. This classification reflects the medical need for monitoring mineral levels.

---

Q: Is Calcidose Vitamine D3 used for osteoporosis?

Yes, official therapeutic indications state that Calcidose Vitamine D3 is used as a calcium and Vitamin D supplement as an adjunct to specific osteoporosis treatment. This is for patients who are at risk of a combined deficiency of these two minerals.

---

Q: Can Calcidose Vitamine D3 cause stomach upset or constipation?

Official regulatory documents list several gastrointestinal issues as common side effects. These can include constipation, flatulence, abdominal pain, and nausea.

---

Q: Does Calcidose Vitamine D3 affect the kidneys?

The medicine is contraindicated in severe renal impairment. Because the active ingredients affect mineral balance, long-term use requires monitoring of kidney function (serum creatinine) to detect and prevent potential calcification in soft tissues caused by high calcium levels.

---

Q: Is it normal to feel a metallic taste after taking Calcidose Vitamine D3?

A metallic taste in the mouth is not listed as a common or expected side effect in the official product information. While uncommon, it is sometimes mentioned in medical literature as a possible symptom associated with high levels of Vitamin D. The appearance of unusual symptoms is typically a reason to contact a healthcare professional.

---

Q: What kind of research has been done on Calcidose Vitamine D3?

Official regulatory documents refer to clinical studies that provide the evidence base for its use. These studies have indicated that Vitamin D3 and calcium supplementation can significantly reduce the incidence of certain bone fractures in specific elderly populations.

---

Q: Does this medicine contain sugar or sweeteners?

Yes, the list of excipients for the powder formulation includes the sweetener sodium saccharine (saccharine sodique). Official labeling may note that formulations containing sugar, if applicable, should be considered for prolonged use.

---

Q: Is it necessary to have a blood test before starting Calcidose Vitamine D3?

Official product information emphasizes the need to exclude pre-existing hypercalcaemia and hypervitaminosis D (high calcium or Vitamin D levels). This typically necessitates the monitoring of calcium and Vitamin D levels by a healthcare provider before and during treatment.

---

Q: What is the evidence base for using Calcidose Vitamine D3 for preventing bone fractures?

Clinical evidence referenced in official documents confirms that when used alongside specific osteoporosis treatments, the product demonstrates a statistically significant reduced risk of hip and non-vertebral fractures in certain high-risk groups, supporting its therapeutic indication.

---

Q: Can Calcidose Vitamine D3 be taken by children?

The official administration instructions for this specific formulation generally state that the medicine is reserved for adult use. The dose strength is typically not recommended for use in children under a specified age.

---

Q: Is Calcidose Vitamine D3 used to treat Rickets?

While the combination product is primarily for deficiency and osteoporosis adjunct therapy in adults, the Vitamin D3 (colecalciferol) component is widely indicated in medical guidelines for the prevention and treatment of rickets and osteomalacia.

---

Q: Does Calcidose Vitamine D3 help with muscle function?

The medicine's mechanism of action described in regulatory documents notes that calcium is a necessary component for several physiological functions, including nerve depolarization and muscle cell excitability. The product aims to stabilize serum calcium levels, which supports these functions.

---

Q: What is the risk profile for patients with a history of kidney stones?

The medicine is contraindicated for patients who have calcium lithiasis (kidney stones). For patients with a history of stones, official documents advise careful supervision and monitoring of urinary calcium excretion to prevent hypercalciuria (excess calcium in the urine).

---

Q: What is the official information regarding overdose?

The primary risk of overdose is hypercalcaemia (excess calcium in the blood), which can lead to symptoms like nausea, vomiting, unusual thirst, and frequent urination. Official information describes that treatment for overdose involves supportive care, which may include discontinuation of calcium and Vitamin D supplements.

---

Q: What is the difference between Calcidose Vitamine D3 and taking a separate calcium pill and a separate Vitamin D pill?

Regulatory documents describe Calcidose Vitamine D3 as a fixed combination product. The formulation is designed to provide high concentrations of both components in a single unit, which is intended to facilitate the absorption of adequate calcium levels with a limited number of doses.

---

Q: What are the most common reasons doctors prescribe Calcidose Vitamine D3?

The official therapeutic indications are for the prevention and treatment of combined Vitamin D and calcium deficiency. It is also commonly prescribed as an adjunct to specific osteoporosis therapy for patients who are considered at risk of these deficiencies.

---

Q: What is the shelf life of Calcidose Vitamine D3?

Official documents specify the shelf life for the intact product, typically listing a period (e.g., 2 or 3 years) when stored according to the manufacturer’s instructions. This information is found in the 'Shelf Life' section of the Summary of Product Characteristics (SmPC) or equivalent product information.

---

Q: Are there official statements regarding stopping the treatment?

Official labeling advises that treatment should be temporarily reduced or interrupted if signs of hypercalcaemia (excess calcium in the blood) or hypercalciuria (excess calcium in the urine) are found. It may be discontinued completely in cases of suspected overdose.

---

Q: Does Calcidose Vitamine D3 contain any artificial coloring?

The listed excipients for the powder formulation generally do not include artificial colorants. The product typically includes various flavorings, such as citrus and vanilla essences.

---

Q: How does the dosage of Vitamin D3 in Calcidose compare to general daily intake recommendations?

The standard daily dosage of two sachets provides a total of 800 IU of Vitamin D3. This dose aligns with or is above the recommended daily intake for adults and is primarily intended to correct or prevent a documented deficiency.

Storage and Disposal of Calcidose Vitamine D3

Official regulatory information states that no particular conservation precautions are necessary for the Calcidose Vitamine D3 powder for oral solution as supplied in the unopened sachet. This indicates the product is stable under normal conditions.

The medicine must be stored out of the sight and reach of children to prevent accidental ingestion. You must not use the medicine after the expiry date printed on the box.

Disposal Requirements

When disposing of unused or expired product, the medicine must not be thrown away with household wastewater or general household waste. Consult your pharmacist for instructions on how to properly discard the unused medicine in accordance with local environmental regulations.